Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123445
Filing Date
2024-11-07
Accepted
2024-11-07 16:40:23
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bioa-20240930.htm   iXBRL 10-Q 2346243
2 EX-3.1 bioa-ex3_1.htm EX-3.1 56579
3 EX-3.2 bioa-ex3_2.htm EX-3.2 315023
4 EX-10.9 bioa-ex10_9.htm EX-10.9 766799
5 EX-31.1 bioa-ex31_1.htm EX-31.1 13083
6 EX-31.2 bioa-ex31_2.htm EX-31.2 14279
7 EX-32.1 bioa-ex32_1.htm EX-32.1 7633
8 EX-32.2 bioa-ex32_2.htm EX-32.2 7698
9 GRAPHIC img41276954_0.jpg GRAPHIC 137542
10 GRAPHIC img250724147_0.jpg GRAPHIC 374898
  Complete submission text file 0000950170-24-123445.txt   9992837

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20240930.xsd EX-101.SCH 1043131
71 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20240930_htm.xml XML 1063165
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42279 | Film No.: 241436610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)